...
首页> 外文期刊>OncoTargets and therapy >Screening of feature genes in distinguishing different types of breast cancer using support vector machine
【24h】

Screening of feature genes in distinguishing different types of breast cancer using support vector machine

机译:使用支持向量机筛选区分不同类型乳腺癌的特征基因

获取原文
           

摘要

Objective: To screen the feature genes in estrogen receptor-positive (ER+) breast cancer in comparison with estrogen receptor-negative (ER-) breast cancer. Methods: Nine microarray data of ER+ and ER- breast cancer samples were collected from Gene Expression Omnibus database. After preprocessing, data in five training sets were analyzed using significance analysis of microarrays to screen the differentially expressed genes (DEGs). The DEGs were further analyzed via support vector machine (SVM) function in e1071 package of R to construct a SVM classifier, the efficacy of which was verified by four testing sets and its combination with training sets using a leave-one-out cross-validation. Feature genes obtained by SVM classifier were subjected to function- and pathway-enrichment via the Database for Annotation, Visualization and Integrated Discovery and KEGG Orthology Based Annotation System, respectively. Results: A total of 526 DEGs were screened between ER+ and ER- breast cancer. The SVM classifier demonstrated that these genes could distinguish different subtype samples with high accuracy of larger than 90%, and also showed good sensitivity, specificity, positiveegative predictive value, and area under receiver operating characteristic curve. The inflammatory and hormone biological processes were the common enriched results for two different function analyses, indicating that the inflammatory (ie, IL8) and hormone regulation (ie, CGA) genes may be the involved feature genes to distinguish ER+ and ER- types of breast cancer. Conclusion: The gene-expression profile data can provide feature genes to distinguish ER+ and ER- samples, and the identified genes can be used for biomarkers for ER+ samples.
机译:目的:与雌激素受体阴性(ER-)乳腺癌相比,筛选雌激素受体阳性(ER +)乳腺癌的特征基因。方法:从Gene Expression Omnibus数据库收集了ER +和ER-乳腺癌样品的9个微阵列数据。预处理后,使用微阵列的显着性分析来分析五个训练集中的数据,以筛选差异表达的基因(DEG)。通过R的e1071程序包中的支持向量机(SVM)函数对DEG进行进一步分析,以构建SVM分类器,并通过四个测试集及其与训练集的组合使用留一法交叉验证来验证其有效性。 。将SVM分类器获得的特征基因分别通过注释,可视化和集成发现数据库以及基于KEGG Orthology的注释系统进行功能和途径富集。结果:在ER +和ER-乳腺癌之间共筛选了526个DEG。 SVM分类器表明,这些基因可以以90%以上的准确度区分不同的亚型样本,并且还显示出良好的灵敏度,特异性,正/负预测值以及接收器工作特征曲线下的面积。炎症和激素的生物学过程是两种不同功能分析的共同丰富结果,表明炎症(即IL8)和激素调节(即CGA)基因可能是区分乳腺ER +和ER-类型的特征基因癌症。结论:基因表达谱数据可提供特征基因以区分ER +和ER-样品,鉴定出的基因可作为ER +样品的生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号